Akèy › Kansè kolon › Florid › Tampa
Etid klinik pou Kansè kolon nan Tampa, FL
13 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Tampa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Ap rekriteFaz 1
- ALX Center 7, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Ap rekriteFaz 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Ap rekriteFaz 3
- Tampa General Hospital-Cancer Institute, Tampa
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Ap rekriteFaz 2/3
- Tampa General Hospital, Tampa
- Moffitt Cancer Center-International Plaza, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
- ak 2 plis
Shield Post-Approval Study Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NMC Research, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Ap rekriteFaz 1
- Moffitt Cancer Center, Tampa
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
Ap rekrite
- Tampa General Hospital, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
- Moffitt Cancer Center, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Ap rekriteFaz 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Ap rekriteFaz 1/2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
- Moffitt Cancer Center, Tampa
Etid Kansè kolon nan lòt vil
- Boston, MA22 etid
- New York City, NY22 etid
- Houston, TX20 etid
- Los Angeles, CA16 etid
- Nashville, TN16 etid
- St. Louis, MO15 etid
- Arlington, VA15 etid
- Chicago, IL14 etid
- San Antonio, TX14 etid
- Baldwin Park, CA14 etid
- Baltimore, MD13 etid
- Washington, DC12 etid
Lòt etid nan Tampa
- Kansè Poumon ki pa ti selil51 etid
- Kansè nan tete43 etid
- Kansè (tout kalite)39 etid
- Kansè kolorektal34 etid
- Leksemi mieloïd egi29 etid
- Kansè Metastatik29 etid
- Kansè poumon29 etid
- Kansè pankreyas26 etid
- Kansè ovè21 etid
- Melanom19 etid
- Sendwòm myelodisplastik19 etid
- Kansè pwostat18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.